Security key
03843E104
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST)
CUSIP: 03843E104
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 120,192,308
- Total 13F shares
- 14,914,775
- Share change
- -969,968
- Total reported value
- $13,452,963
- Put/Call ratio
- 1.6%
- Price per share
- $0.90
- Number of holders
- 34
- Value change
- -$924,306
- Number of buys
- 7
- Number of sells
- 22
Report period
Q4 2022
Institutions
34
Top holders
10
AQST full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Aquestive Therapeutics, Inc. SEC filings
Aquestive Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 03843E104
Recent filing periods:
Top shareholders of AQST - Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Bratton Capital Management, L.P. |
13F
|
Company |
8.2%
|
9,810,958
|
$11,479,000 | — | 30 Sep 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.98%
|
1,181,540
|
$1,382,000 | — | 30 Sep 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.75%
|
900,800
|
$1,054,000 | — | 30 Sep 2022 | |
| Vahanian & Associates Financial Planning Inc. |
13F
|
Company |
0.58%
|
695,258
|
$813,000 | — | 30 Sep 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.4%
|
475,871
|
$557,000 | — | 30 Sep 2022 | |
| Bracebridge Capital, LLC |
13F
|
Company |
0.36%
|
428,571
|
$501,000 | — | 30 Sep 2022 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.34%
|
406,700
|
$475,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.31%
|
373,878
|
$437,000 | — | 30 Sep 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
365,899
|
$428,000 | — | 30 Sep 2022 | |
| Latash Investments, LLC |
13F
|
Company |
0.2%
|
243,134
|
$284,000 | — | 30 Sep 2022 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.12%
|
142,956
|
$167,000 | — | 30 Sep 2022 | |
| HighTower Advisors, LLC |
13F
|
Company |
0.11%
|
130,305
|
$152,000 | — | 30 Sep 2022 | |
| STATE STREET CORP |
13F
|
Company |
0.08%
|
96,037
|
$112,000 | — | 30 Sep 2022 | |
| Man Group plc |
13F
|
Company |
0.07%
|
89,900
|
$105,000 | — | 30 Sep 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.05%
|
62,090
|
$73,000 | — | 30 Sep 2022 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.05%
|
60,000
|
$70,000 | — | 30 Sep 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.03%
|
39,900
|
$47,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.03%
|
34,875
|
$41,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
33,381
|
$39,000 | — | 30 Sep 2022 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.02%
|
29,942
|
$35,000 | — | 30 Sep 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.02%
|
27,704
|
$32,000 | — | 30 Sep 2022 | |
| Financial Advocates Investment Management |
13F
|
Company |
0.02%
|
27,000
|
$32,000 | — | 30 Sep 2022 | |
| Cresset Asset Management, LLC |
13F
|
Company |
0.02%
|
26,000
|
$30,000 | — | 30 Sep 2022 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
23,850
|
$28,000 | — | 30 Sep 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.02%
|
21,100
|
$25,000 | — | 30 Sep 2022 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
20,318
|
$24,000 | — | 30 Sep 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.02%
|
20,000
|
$23,000 | — | 30 Sep 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
18,063
|
$21,000 | — | 30 Sep 2022 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
17,730
|
$21,000 | — | 30 Sep 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.01%
|
14,853
|
$17,000 | — | 30 Sep 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.01%
|
13,704
|
$16,000 | — | 30 Sep 2022 | |
| D.B. Root & Company, LLC |
13F
|
Company |
0.01%
|
12,500
|
$14,000 | — | 30 Sep 2022 | |
| Bayesian Capital Management, LP |
13F
|
Company |
0.01%
|
10,235
|
$12,000 | — | 30 Sep 2022 | |
| Running Point Capital Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$12,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
9,068
|
$11,000 | — | 30 Sep 2022 | |
| IFP Advisors, Inc |
13F
|
Company |
0.01%
|
6,500
|
$104,000 | — | 30 Sep 2022 | |
| Quantbot Technologies LP |
13F
|
Company |
0%
|
3,751
|
$4,000 | — | 30 Sep 2022 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0%
|
3,166
|
$3,000 | — | 30 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
2,447
|
$3,000 | — | 30 Sep 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,000
|
$2,000 | — | 30 Sep 2022 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 30 Sep 2022 | |
| TCI Wealth Advisors, Inc. |
13F
|
Company |
0%
|
500
|
$1,000 | — | 30 Sep 2022 | |
| China Universal Asset Management Co., Ltd. |
13F
|
Company |
0%
|
499
|
$1,000 | — | 30 Sep 2022 | |
| James S. Scibetta |
3/4/5
|
Director |
—
mixed-class rows
|
51,635
mixed-class rows
|
$25,624 | — | 15 Jun 2021 | |
| Keith J. Kendall |
3/4/5
|
CEO and President, Director |
—
class O/S missing
|
375,000
|
— | — | 10 Mar 2022 | |
| Kenneth Truitt |
3/4/5
|
Chief Medical Officer |
—
class O/S missing
|
100,000
|
— | — | 06 Sep 2022 | |
| Theresa Wood |
3/4/5
|
SVP-HR and Org. Development |
—
class O/S missing
|
70,000
|
— | — | 10 Mar 2022 | |
| Nancy Lurker |
3/4/5
|
Director |
—
class O/S missing
|
20,000
|
— | — | 15 Jun 2021 |
Institutional Holders of Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) as of Q4 2022
As of 31 Dec 2022,
Aquestive Therapeutics, Inc. - Common Stock, $0.001 par value (AQST) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
14,914,775 shares.
The largest 10 holders included
Bratton Capital Management, L.P., VANGUARD GROUP INC, Vahanian & Associates Financial Planning Inc., Schonfeld Strategic Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, Bracebridge Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Latash Investments, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
41
Q4 2022 holders
34
Holder diff
-7
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.